U.S. orphan drug designation awarded to Dicerna's DCR-PH1 for primary hyperoxaluria type 1 April 24, 2015
Euroscreen starts phase II trials of ESN-364 in uterine fibroids and polycystic ovary syndrome April 22, 2015
RSS